<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "aldesleukin inj VIAL">
<dose><value>600 000</value>
<value>600 000 - 720 000</value>
<value>18 000 000</value>
<value>9 000 000</value>
</dose>
<route><value>IV</value>
<value>SC</value>
</route>
<strength><value>22 million unit</value>
</strength>
<frequency><value>Q8H</value>
<value>DAILY</value>
</frequency>
<instruction><value>Administer over 15 minutes for 14 doses.</value>
<value>for 5 days, then rest 2 days.</value>
<value>for 2 days.</value>
<value>for 3 days.</value>
</instruction>
<volume></volume>
<units><value>unit/kg/dose</value>
<value>unit </value>
<value>unit</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Malignant Melanoma. Treatment schedule = 14 doses, rest 9 days.</value>
<value>Renal Cell Carcinoma.  Treatment schedule = 14 doses, followed by 9 days of rest.</value>
<value>Renal Cell Carcinoma. Treatment schedule: 18 million units SC DAILY for 5 days, rest 2 days, then 9 million units SC DAILY for 2 days, then 18 million units SC DAILY for 3 days.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3334</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>